Author: Su, Junhui; Chang, Cui; Xiang, Qi; Zhou, Zhi-Wei; Luo, Rong; Yang, Lun; He, Zhi-Xu; Yang, Hongtu; Li, Jianan; Bei, Yu; Xu, Jinmei; Zhang, Minjing; Zhang, Qihao; Su, Zhijian; Huang, Yadong; Pang, Jiyan; Zhou, Shu-Feng
Title: Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study Document date: 2014_12_12
ID: y14atmnh_94
Snippet: Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin, and plasminogen activator. The aberrant form inhibits insulin-induced nitric oxide synthesis in platelets, decreases coagulation time, and has proteolytic activity against insulin and plasmin. The short peptide from AAT is a reversible chymotrypsin inhibitor. It also inhibits ela.....
Document: Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin, and plasminogen activator. The aberrant form inhibits insulin-induced nitric oxide synthesis in platelets, decreases coagulation time, and has proteolytic activity against insulin and plasmin. The short peptide from AAT is a reversible chymotrypsin inhibitor. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase.
Search related documents:
Co phrase search for related documents- AAT short peptide and chymotrypsin inhibitor: 1
- AAT short peptide and coagulation time: 1
- AAT short peptide and human leukocyte elastase: 1
- AAT short peptide and human leukocyte elastase proteolytic destruction: 1
- AAT short peptide and major physiological function: 1
- AAT short peptide and moderate affinity: 1
- AAT short peptide and nitric oxide: 1
- AAT short peptide and nitric oxide synthesis: 1
- AAT short peptide and physiological function: 1
- AAT short peptide and plasmin insulin: 1
- AAT short peptide and plasmin insulin proteolytic activity: 1
- AAT short peptide and plasminogen activator: 1
- aberrant form and moderate affinity: 1
- aberrant form and nitric oxide: 1
- aberrant form and nitric oxide synthesis: 1
- aberrant form and physiological function: 1
- aberrant form and plasmin insulin: 1
- aberrant form and plasmin insulin proteolytic activity: 1
- aberrant form and plasminogen activator: 1
Co phrase search for related documents, hyperlinks ordered by date